Related Experiment Video

Updated: Aug 14, 2026

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
09:32

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Published on: September 10, 2017

Targeting p53 by PTD-mediated transduction

Wenge Wang1, Wafik S El-Deiry

  • 1Laboratory of Molecular Oncology and Cell Cycle Regulation, Howard Hughes Medical Institute, Department of Medicine, University of Pennsylvania School of Medicine, 415 Curie Blvd CRB 437, Philadelphia, PA 19104, USA.

Trends in Biotechnology
|August 28, 2004
PubMed

Insights

Restoring tumor suppressor p53 activity is key for cancer therapy. Protein transduction domains (PTDs) enable peptide delivery, enhanced by influenza HA2 protein to improve p53 peptide therapy efficacy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biotechnology

Background:

  • The p53 tumor suppressor is a critical target for cancer treatment strategies.
  • Current approaches include p53 gene overexpression and small molecule-based rescue of mutant p53.
  • p53 peptides show promise in activating p53 responses in various cancer cell types.

Purpose of the Study:

  • To investigate the potential of protein transduction domain (PTD)-mediated delivery for p53 peptides.
  • To enhance the cellular uptake and functional impact of p53-based therapeutic cargos.
  • To explore the role of influenza hemagglutinin protein (HA2) in improving PTD delivery.

Main Methods:

  • Utilized PTD-conjugated peptides targeting the p53 carboxyl terminus for cell entry.
  • Investigated PTD-mediated cellular uptake via macropinocytosis.
  • Employed the influenza virus hemagglutinin protein (HA2) to disrupt macropinocytosomes and facilitate cargo escape.

Main Results:

  • PTD-mediated delivery successfully introduced p53 peptides into cells.
  • PTD-mediated transfer occurred through macropinocytosis.
  • Co-delivery with HA2 significantly enhanced the escape of PTD-cargos from macropinocytosomes, boosting functional outcomes.

Conclusions:

  • PTD technology offers a viable strategy for delivering p53 peptides and other large molecular cargos into cells.
  • The destabilization of macropinocytosomes by HA2 is crucial for efficient intracellular cargo delivery.
  • This combined approach holds significant potential for advancing p53-based tumor therapies.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...